Phase I Study of Adoptive Immunotherapy With Enriched and Expanded Autologous Natural Killer (NK) Cells for Patients With Ph+ Acute Lymphoblastic Leukemia (ALL)

Clinical trial NCT02185781 · COMPLETED

Trial details

NCT number: NCT02185781
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Complete Hematologic Remission (CHR)Persistent/Recurrent Minimal Residual Disease (MRD)

Start date: 2015-01-28
Primary completion: 2021-11-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.